semaglutide depression & Mental Health Study: Weight loss drug GLP-1

Russell-Jones D, Gall M-A, Niemeyer M et al (2015) Insulin degludec results in lower rates of nocturnal hypoglycaemia and fasting plasma glucose vs

But I maintain that while we know the current cost, but have only just begun to understand the benefits conferred by these important medicines

In animal studies, GLP-1RAs consistently reduced drug intake, weakened dopamine release in reward neural networks, and reduced the probability of relapse

Specifically, the ratio of total fat and protein to energy intake was significantly linked to depressive symptoms in Hispanics, dietary fiber to sugar ratio in whites, total energy intake in blacks, and total sugar to dietary fiber ratio in Asians